Literature DB >> 28236861

Effect of dexmedetomidine on acute lung injury in experimental ischemia-reperfusion model.

Ömer Burak Küçükebe1, Deniz Özzeybek2, Ruslan Abdullayev3, Adil Ustaoğlu4, Işıl Tekmen5, Tuncay Küme6.   

Abstract

PURPOSE: Ischemia-reperfusion injury is one of the consequences of tourniquet application for extremity surgery. The aim of the study was to establish the effect of dexmedetomidine on the acute lung injury following lower extremity experimental ischemia-reperfusion model in rats.
METHODS: Twenty-eight Wistar-Albino breed Rats were recruited after Ethics Committee approval and allocated into 4 groups, each with 7 subjects. Group 1 (SHAM) received only anesthesia. Group 2 (IR) had experienced 3h of ischemia and 3h of reperfusion using left lower extremity tourniquet after anesthesia application. Groups 3 (D-50) and 4 (D-100) had undergone the same procedures as in the Group 2, except for receiving 50 and 100mg·kg-1, respectively, dexmedetomidine intraperitoneally 1h before the tourniquet release. Blood samples were obtained for the analysis of tumor necrosing factor-α and interleukin-6. Pulmonary tissue samples were obtained for histological analysis.
RESULTS: No significant difference regarding blood tumor necrosing factor-α and interleukin-6 values was found among the groups, whereas pulmonary tissue injury scores revealed significant difference. Histological scores obtained from the Group 2 were significantly higher from those in the Groups 1, 3 and 4 with p-values 0.001 for each comparison. Moreover, Group 1 scores were found to be significantly lower than those in the Groups 3 and 4 with p-values 0.001 and 0.011, respectively. No significant difference was observed between the Groups 3 and 4.
CONCLUSION: Dexmedetomidine is effective in reduction of the experimental ischemia-reperfusion induced pulmonary tissue injury in rats, formed by extremity tourniquet application.
Copyright © 2016 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Acute lung injury; Dexmedetomidina; Dexmedetomidine; Experimental; Lesão de reperfusão; Lesão pulmonar aguda; Reperfusion injury

Mesh:

Substances:

Year:  2016        PMID: 28236861     DOI: 10.1016/j.bjane.2015.08.002

Source DB:  PubMed          Journal:  Braz J Anesthesiol


  5 in total

1.  The Role of Melatonin in Electroacupuncture Alleviating Lung Injury Induced by Limb Ischemia-Reperfusion in Rabbits.

Authors:  Shu-An Dong; Li-Rong Gong; Jian-Bo Yu; Yong-Xing Kan
Journal:  Med Sci Monit       Date:  2020-05-19

2.  Pre-cardiopulmonary bypass administration of dexmedetomidine decreases cardiac troponin I level following cardiac surgery with sevoflurane postconditioning.

Authors:  Hong-Mei Zhou; Xiao-Yan Ling; Yun-Jian Ni; Cheng Wu; Zhi-Peng Zhu
Journal:  J Int Med Res       Date:  2019-06-24       Impact factor: 1.671

3.  The effects of amantadine on lung tissue in lower limb ischemia/reperfusion injury model in rats.

Authors:  Mustafa Orhan; Ayça Taş Tuna; Yusuf Ünal; Mustafa Arslan; Hayrullah Yazar; Şaban Cem Sezen; Sezen Irmak Gözükara; Onur Palabıyık
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-01-13       Impact factor: 0.332

4.  Dexmedetomidine inhibits inflammatory response and autophagy through the circLrp1b/miR-27a-3p/Dram2 pathway in a rat model of traumatic brain injury.

Authors:  Hengchang Li; Chengxiang Lu; Wenfei Yao; Lixin Xu; Jun Zhou; Bin Zheng
Journal:  Aging (Albany NY)       Date:  2020-11-04       Impact factor: 5.682

5.  The Effects of Dexmedetomidine and Ketamine on Oxidative Injuries and Histological Changes Following Blunt Chest Trauma.

Authors:  Seyfi Kartal; Gülay Kip; Ayşegül Küçük; Seyhan Sümeyra Aşçı; Özlem Erdem; Mustafa Arslan; Mustafa Kavutçu
Journal:  Drug Des Devel Ther       Date:  2020-07-23       Impact factor: 4.319

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.